Search results
The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views -...
Financial Post· 6 days agoDUBLIN — “The Corporate Reputation of Pharma in 2023/2024 – The Patient Perspective – Canada Edition – The Views of 100 Canadian Patient Groups” report has been added to ResearchAndMarkets.com ...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
Digital Journal· 5 days agoNurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce a pre-clinical study to explore ...
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
Digital Journal· 5 days agoBOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to ...